Patents by Inventor Judith Hailey

Judith Hailey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neutralizing human anti-IGFR antibody
    Patent number: 8173779
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Grant
    Filed: November 8, 2010
    Date of Patent: May 8, 2012
    Assignee: Schering Corporation
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan A. Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • NEUTRALIZING HUMAN ANTI-IGFR ANTIBODY
    Publication number: 20110060130
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Application
    Filed: November 8, 2010
    Publication date: March 10, 2011
    Inventors: YAN WANG, ROBERT GREENBERG, LEONARD PRESTA, JONATHAN A. PACHTER, JUDITH HAILEY, PETER BRAMS, DENISE WILLIAMS, MOHAN SRINIVASAN, DIANE FEINGERSH
  • Neutralizing human anti-IGFR antibody
    Patent number: 7851181
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: December 14, 2010
    Assignee: Schering Corporation
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan A. Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • Neutralizing human anti-IGFR antibody
    Patent number: 7847068
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: December 7, 2010
    Assignee: Schering Corporation
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan A. Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • Neutralizing human anti-IGFR antibody
    Patent number: 7667021
    Abstract: The present invention includes isolated nucleic acids encoding fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). Also included are methods of using and producing the antibodies of the invention.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: February 23, 2010
    Assignee: Schering Corporation
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan A. Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • NEUTRALIZING HUMAN ANTI-IGFR ANTIBODY
    Publication number: 20080014197
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Application
    Filed: August 8, 2007
    Publication date: January 17, 2008
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • Neutralizing human anti-IGFR antibody
    Patent number: 7217796
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Grant
    Filed: May 22, 2003
    Date of Patent: May 15, 2007
    Assignee: Schering Corporation
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan A. Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • Neutralizing human anti-IGFR antibody
    Publication number: 20070059241
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Application
    Filed: November 13, 2006
    Publication date: March 15, 2007
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • Neutralizing human anti-IGFR antibody
    Publication number: 20070059305
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Application
    Filed: November 13, 2006
    Publication date: March 15, 2007
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh
  • Neutralizing human anti-IGFR antibody
    Publication number: 20040018191
    Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
    Type: Application
    Filed: May 22, 2003
    Publication date: January 29, 2004
    Applicant: Schering Corporation
    Inventors: Yan Wang, Robert Greenberg, Leonard Presta, Jonathan A. Pachter, Judith Hailey, Peter Brams, Denise Williams, Mohan Srinivasan, Diane Feingersh